PetIQ, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PETQ research report →
Range $31 – $31
Price Chart
About the company
PetIQ, Inc. operates as a prominent enterprise in the pet health and wellness sector, with a market presence across the United States and internationally. Its operations are strategically divided into two primary segments: Products and Services.
- CEO
- McCord Christensen
- IPO
- 2017
- Employees
- 1,121
- HQ
- Eagle, ID, US
Get TickerSpark's AI analysis on PETQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $919.17M
- P/E
- 423.80
- Fwd P/E
- 17.02
- PEG
- 3.03
- P/S
- 0.83
- P/B
- 4.08
- EV/EBITDA
- 15.69
- Div Yield
- 0.00%
- Gross Margin
- 22.94%
- Op Margin
- 5.45%
- Net Margin
- 0.19%
- ROE
- 0.99%
- ROIC
- 8.54%
Latest fiscal year · YoY change
- Revenue
- $1.10B+19.6%
- Gross Profit
- $252.74M+20.5%
- Op Income
- $60.02M
- Net Income
- $2.13M+104.4%
- EPS
- $0.07+104.4%
- OCF Growth
- +28.9%
- FCF Growth
- +46.3%
- 52W High
- $31.06
- 52W Low
- $15.09
- 50D MA
- $30.71
- 200D MA
- $22.28
- Beta
- 1.74
- RSI (14)
- 80
- Avg Volume
- 884.43K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
PetIQ said Q1 was a record quarter, with broad-based brand growth, higher margins, and a raised 2024 outlook.· May 8, 2024
- Q1 net sales were a record $308.4 million, with EPS of $0.48 and adjusted EBITDA of $35.3 million, both above guidance.
- Gross margin expanded 280 basis points to 24.2%, helped by higher-margin manufactured brands and Services optimization.
- Products drove the quarter: segment sales rose to $276.9 million, with PetIQ brands up 14.3% and OTC flea-and-tick share gains continuing.
- Services sales were roughly flat at $31.6 million, but gross margin improved 810 basis points after closing 149 wellness centers.
- Management raised full-year 2024 guidance for net sales, adjusted EBITDA, and free cash flow.
- The company also said marketing spend will step up in 2024, including about $6 million more in Q2 versus last year.
PetIQ reported Q1 2024 net sales of $308.4 million, up 6.2% year over year, with gross profit of $74.5 million versus $62.3 million last year and gross margin of 24.2%, up 280 basis points from 21.4%. Net income was $14.9 million, or EPS of $0.48, up 47.8% year over year; adjusted net income was $18.5 million and adjusted EPS was $0.53, up 32.5%. Adjusted EBITDA increased 15% year over year to $35.3 million, with adjusted EBITDA margin of 11.4%, up 80 basis points. For 2024, the company raised free cash flow guidance to an excess of $50 million from an excess of $45 million, and expects full-year net sales of $1.135 billion to $1.185 billion and adjusted EBITDA of $112 million to $117 million. For Q2 2024, it guided to net sales of $325 million to $335 million and adjusted EBITDA of $34 million to $36 million.
Cord Christensen framed the quarter as a strong start to 2024, emphasizing broad-based growth across product categories and channels. He said the company is investing more in brand-building and marketing to support long-term growth, and highlighted share gains in flea-and-tick, supplements, dental treats, and Rocco & Roxie. His tone was upbeat and confident, but he also noted that PetIQ is watching category conditions more closely and remains disciplined about where it spends.
Zvi Glasman highlighted the key financial drivers: gross profit of $74.5 million, gross margin of 24.2%, adjusted SG&A of $47.1 million, adjusted EPS of $0.53, and adjusted EBITDA of $35.3 million. He said the margin improvement came from stronger higher-margin manufactured brands, operational efficiencies, and the Services restructuring, while SG&A rose mainly because of $4.7 million of added marketing expense. On the balance sheet, he said cash was $25.4 million, total debt was $443.9 million, the $125 million ABL was undrawn, total liquidity was $150.4 million, and net leverage improved to 3.6x from 4.5x in 2023. He also said the company raised 2024 free cash flow guidance to more than $50 million and completed the sale of Mark & Chappell for about $4 million in net cash proceeds, with an expected $1.7 million loss.
Analysts focused on whether Q1 gross margin strength is sustainable, and management said the improvement was driven by mix, better manufacturing performance, and Services optimization, not just a one-time factor. They said margins should continue trending higher through the year, with full-year margin improvement now expected at 75 basis points plus, though quarter-to-quarter results will not be linear. Questions also centered on consumer health and flea-and-tick seasonality; management said they are not seeing pet care trade-down behavior and that the season is running slightly better than originally modeled, closer to a 4% to 5% category growth rate versus the 3% assumption. Analysts also pressed on Rocco & Roxie and Services, and management said Rocco & Roxie distribution expansions are playing out as expected, with more impact to come in Q2 and beyond, while Services labor and cancellation trends have improved materially.
The call showed broad momentum across PetIQ’s core brands, with management saying manufactured products are accelerating faster than expected and gaining share in growing categories. Margin leverage appears to be real, with both Products and Services contributing, and management raised full-year sales, EBITDA, and free cash flow guidance.
Management acknowledged higher marketing spend, with about $12 million of incremental investment planned for the year and $6 million more in Q2 versus last year, which will pressure SG&A. They also noted that category conditions and flea-and-tick seasonality remain variable, Q1 leverage is seasonally the highest of the year, and inventory was somewhat elevated due to seasonal build and timing of distribution partner inventory.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 82.2%
- Shares Outstanding
- 29.67M
- Float Shares
- 24.40M
of shares held by institutions
191 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for PETQ, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock Inc. | 3.01M | ▲ 79.96K |
| Clarivest Asset Management LLC | 94.60K | 0 |
| Crystalline Management Inc. | 60.00K | ▲ 60.00K |
| Putnam Investments LLC | 47.33K | ▼ 1.50K |
| Credit Suisse AG/ | 33.80K | 0 |
| Ica Group Wealth Management, LLC | 91 | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 24, 24 | Glasman Zvi | other | 21,268 |
| Oct 25, 24 | Glasman Zvi | sell | 36,513 |
| Oct 25, 24 | Glasman Zvi | sell | 21,268 |
| Oct 25, 24 | Glasman Zvi | sell | 16,000 |
| Oct 25, 24 | Huff Scott | sell | 4,103 |
| Oct 25, 24 | Huff Scott | sell | 6,077 |
| Oct 24, 24 | Lyon Chad D. | other | 13,985 |
| Oct 25, 24 | Lyon Chad D. | sell | 178 |
| Oct 25, 24 | Lyon Chad D. | sell | 6,311 |
| Oct 25, 24 | Lyon Chad D. | sell | 10,987 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PETQ coverage
Recent articles, reports, and earnings notes.
No research on PETQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PETQ report →Bansk Group Announces Sale of PetIQ's Veterinary Services Business to Tractor Supply Company
prnewswire.com · May 28
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group
globenewswire.com · Oct 25
PetIQ, Inc. Announces Results of Special Meeting of Stockholders
globenewswire.com · Oct 22
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Upcoming Votes of PETQ and FBMS
accesswire.com · Oct 9
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS
accesswire.com · Oct 8
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS
accesswire.com · Oct 7
PetIQ, Inc. (PETQ) Hits Fresh High: Is There Still Room to Run?
zacks.com · Oct 3
Fast-paced Momentum Stock PetIQ (PETQ) Is Still Trading at a Bargain
zacks.com · Sep 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.